Our study presents a conversational agent with multiple functionalities and shows that GPT-4o outperforms Llama 3.1-8B in performance, although at a higher cost. This platform could be used in future clinical trials or real-world implementation studies.
Villarreal-Zegarra et al. (Wed,) studied this question.